EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

The novel use of the human nasal epithelial cell line RPMI 2650 as an in vitro model to study the influence of allergens and cytokines on transforming growth factor-beta gene expression and protein release



The novel use of the human nasal epithelial cell line RPMI 2650 as an in vitro model to study the influence of allergens and cytokines on transforming growth factor-beta gene expression and protein release



Clinical and Experimental Allergy 35(6): 811-819



The epithelial accumulation of mast cells is a feature of allergic rhinitis and this has been linked to the expression of the known mast cell chemoattractant transforming growth factor-beta (TGF-beta) at this site. Little is known concerning the regulation of TGF-beta gene expression or protein release by nasal epithelial cells.

(PDF same-day service: $19.90)

Accession: 012668528

Download citation: RISBibTeXText

PMID: 15969674

DOI: 10.1111/j.1365-2222.2005.02258.x



Related references

The characterization of the human nasal epithelial cell line RPMI 2650 under different culture conditions and their optimization for an appropriate in vitro nasal model. Pharmaceutical Research 32(2): 665-679, 2015

Evaluation of the human cell line RPMI 2650 as an in vitro nasal model. Rhinology 33(4): 194-198, 1995

RPMI 2650 epithelial model and three-dimensional reconstructed human nasal mucosa as in vitro models for nasal permeation studies. European Journal of Pharmaceutics and Biopharmaceutics 74(2): 290-297, 2010

Roles of epidermal growth factor receptor signaling pathway on cultured human nasal epithelial cells RPMI-2650. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 44(3): 203-208, 2011

Transforming growth factor-beta 1 downregulates dexamethasone-induced tetranectin gene expression during the in vitro mineralization of the human osteoblastic cell line SV-HFO. Febs Letters 373(1): 1-4, 1995

Retinoic acid and hydrocortisone strengthen the barrier function of human RPMI 2650 cells, a model for nasal epithelial permeability. Cytotechnology 65(3): 395-406, 2012

Transfection and expression of mutant p53 protein does not alter the in vivo or in vitro growth characteristics of the AA/C1 human adenoma derived cell line, including sensitivity to transforming growth factor-beta 1. Oncogene 9(5): 1479-1485, 1994

Activity of Multidrug Resistance-Associated Proteins 1-5 (MRP1-5) in the RPMI 2650 Cell Line and Explants of Human Nasal Turbinate. Molecular Pharmaceutics 14(5): 1577-1590, 2017

Altered gene expression of c myc epidermal growth factor receptor transforming growth factor alpha and c erb b2 in an immortalized human breast epithelial cell line hmt 3522 is associated with decreased growth factor requirements. Cancer Research 52(5): 1210-1217, 1992

Transforming growth factor beta-regulated gene expression in a mouse mammary gland epithelial cell line. Breast Cancer Research 5(6): R187-R198, 2003

Effect of transforming growth factor-beta on the activity of connective tissue growth factor gene promoter in human renal proximal tubular epithelial cell line HK-2. Journal of the American Society of Nephrology 14(Abstracts Issue): 90A, November, 2003

Transforming growth factor-beta-1 and insulin regulate the release of insulin like growth factor-binding protein-2 in rat intestinal epithelial cell line by different mechanisms. Gastroenterology 106(4 SUPPL ): A812, 1994

Cytotoxicity of Different Excipients on RPMI 2650 Human Nasal Epithelial Cells. Molecules 21(5): -, 2016

Modulation of epidermal growth factor receptor gene expression by transforming growth factor-beta in a human breast carcinoma cell line. Cancer Research 47(16): 4260-4265, 1987

Modulation of epidermal growth factor receptor gene expression by triiodothyronine and transforming growth factor beta in a human breast carcinoma cell line. Journal Of Cellular Biochemistry Supplementrt A: 120, 1988